Like many other multinationals over the past few decades, GlaxoSmithKline came to China for the chance to sell to 1.3 billion new customers in the world’s fastest growing drugs market.
The company has invested heavily here, setting up clinical centers and research facilities in Tianjin and Shanghai. The drugmaker boasts that it has spent more than 1 billion yuan on research and development in China.
Read Full Article HERE
Charles Riley, CNN via CHINA US Focus http://feedproxy.google.com/~r/ChinaUsFocus/~3/kWc9CYjb5oc/
No comments:
Post a Comment